Midkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer

[1] Parkin DM(2001)Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153-156

[2] Bray F(2004)Epidemiology and prevention of pancreatic cancer Jpn J Clin Oncol 34 238-244

[3] Ferlay J(2002)Estimates of cancer incidence and mortality in Europe in 1995 Eur J Cancer 38 99-166

[4] Pisani P(1999)Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1-7

[5] Lowenfels AB(2003)Developments in the systemic therapy of pancreatic cancer Cancer Invest 21 73-86

[6] Maisonneuve P(1996)In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector Hum Gene Ther 7 1503-1514

[7] Bray F(1995)Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy Hum Gene Ther 6 881-893

[8] Sankila R(1996)Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter Gene Ther 3 1094-1103

[9] Ferlay J(1995)Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer Hum Gene Ther 6 1417-1426

[10] Parkin DM(1997)Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells Cancer Res 57 2559-2563

[1] Parkin DM(2001)Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 153-156

[2] Bray F(2004)Epidemiology and prevention of pancreatic cancer Jpn J Clin Oncol 34 238-244

[3] Ferlay J(2002)Estimates of cancer incidence and mortality in Europe in 1995 Eur J Cancer 38 99-166

[4] Pisani P(1999)Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1-7

[5] Lowenfels AB(2003)Developments in the systemic therapy of pancreatic cancer Cancer Invest 21 73-86

[6] Maisonneuve P(1996)In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector Hum Gene Ther 7 1503-1514

[7] Bray F(1995)Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy Hum Gene Ther 6 881-893

[8] Sankila R(1996)Suicide gene expression induced in tumour cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter Gene Ther 3 1094-1103

[9] Ferlay J(1995)Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer Hum Gene Ther 6 1417-1426

[10] Parkin DM(1997)Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells Cancer Res 57 2559-2563